Sign in
CNSY Stock Price, Chart, Stats & News
Cerenome, Inc.
Save
Cerenome, Inc. (CNSY) does not currently pay a dividend.
25.33M
Market cap
–
Current P/E
–
Forward P/E
CNSY chart
1M
3M
1Y
5Y
Loading chart...
About
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS.
Similar securities
Based on sector and market capitalization
Report issue